Delcath Systems (DCTH) Expands Melphalan/HDS Phase 2 Program into U.S.
Tweet Send to a Friend
Delcath Systems (Nasdaq: DCTH) announced the opening of its United States (U.S.) Clinical Development Program for first-line treatment of patients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE